Immunotherapy studies in autologous cell therapies (ACT) present new and unique challenges involving the selection of appropriate sites with the experience and capabilities of running these complex studies. Qualified study sites and team members are essential to safeguard the integrity of the cell product. Following site identification and activation, it is necessary to continuously reevaluate obstacles that may interfere with blood procurement, product manufacture and delivery of treatment doses.


Click here to read our enrollment challenges case study

Contact Us
Call Our Team 

Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373

Corporate Headquarters

3201 Beechleaf Court
Suite 600
Raleigh, NC 27604-1547